Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Prostate 78%
3. Watchful Waiting 75%
4. Struvite 43%
5. Tadalafil 41%
6. Extracorporeal Shockwave Therapy 40%
7. Erectile Dysfunction 37%
8. Lower Urinary Tract Symptoms 34%
9. Lithotripsy 34%
10. anhydrous dibasic calcium phosphate 34%
11. Prostatic Hyperplasia 31%
12. Placebos 31%
13. Urinary Incontinence 31%
14. Psychological Practice 29%
15. Prostate-Specific Antigen 29%
16. Therapeutics 27%
17. Testosterone 25%
18. Cystine 24%
19. Calcium Oxalate 24%
20. Biopsy 24%
21. Genes 24%
22. Income 23%
23. Calculi 22%
24. Referral and Consultation 21%
25. Lymph Nodes 20%
26. Clinical Studies 19%
27. United States Food and Drug Administration 19%
28. Physicians 18%
29. Biomarkers 18%
30. Phosphodiesterase 5 Inhibitors 16%
31. Shock 16%
32. Urologists 15%
33. Prostatectomy 13%
34. In Vitro Techniques 12%
35. Hardness 12%
36. Equipment and Supplies 11%
37. Population 11%
38. Neoplasms 10%
39. Lymph Node Excision 9%
40. Biological Therapy 8%
41. Gels 7%
42. Health Planning 7%
43. Urology 6%
44. Immunohistochemistry 6%
45. Pathology 6%
46. Staining and Labeling 6%
47. Risk Assessment 6%
48. Neoplasm Metastasis 5%